SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-17-018907
Filing Date
2017-11-09
Accepted
2017-11-09 16:23:06
Documents
50
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q inbp20170930_10q.htm 10-Q 572759
2 EXHIBIT 31.1 CERTIFICATION PURSUIT TO SECTION 302 BY CEO ex_98951.htm EX-31.1 12097
3 EXHIBIT 31.2 CERTIFICATION PURSUIT TO SECTION 302 BY CFO ex_98958.htm EX-31.2 13050
4 EXHIBIT 32.1 CERTIFICATION OF FINANCIAL STATEMENTS BY CEO ex_98959.htm EX-32.1 7928
5 EXHIBIT 32.2 CERTIFICATION OF FINANCIAL STATEMENTS BY CFO ex_98960.htm EX-32.2 5948
  Complete submission text file 0001437749-17-018907.txt   3304066

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT inbp-20170930.xml EX-101.INS 638245
7 XBRL TAXONOMY EXTENSION SCHEMA inbp-20170930.xsd EX-101.SCH 39861
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE inbp-20170930_cal.xml EX-101.CAL 36645
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE inbp-20170930_def.xml EX-101.DEF 256874
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE inbp-20170930_lab.xml EX-101.LAB 225586
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE inbp-20170930_pre.xml EX-101.PRE 271677
Mailing Address 225 LONG AVENUE BUILDING 15 HILLSIDE NJ 07205
Business Address 225 LONG AVENUE BUILDING 15 HILLSIDE NJ 07205 9739260816
INTEGRATED BIOPHARMA INC (Filer) CIK: 0001016504 (see all company filings)

IRS No.: 222407475 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-31668 | Film No.: 171191159
SIC: 2834 Pharmaceutical Preparations